(Q81160536)

English

Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

scientific article published on 24 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Expression of urokinase-type plasminogen activator system in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Masafumi Kumano

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Hideaki Miyake

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Mototsugu Muramaki

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Junya Furukawa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Atsushi Takenaka

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Masato Fujisawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

24 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

180-186

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

The urokinase plasminogen activator system: role in malignancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer☆

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.01.012

7 January 2021

Identifiers

10.1016/J.UROLONC.2008.01.012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18439850%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81160536&oldid=1743363766"